Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sunstone Pharmaceutical (now known as China Resources Sanjiu (Tangshan) Pharmaceutical Co., Ltd.) is a leading Chinese specialty pharmaceutical company focused on the development, manufacturing, and marketing of over-the-counter (OTC) pediatric and women's healthcare products. Founded in 1996 and headquartered in Tangshan, Hebei Province, the company is renowned for its flagship brands, 'Hao Wawa' (GoodBaby) for pediatric cough and cold, and 'Kang Fu Te' (Confort) for feminine hygiene and gynecological health. Over its history, the company was acquired by BMP Sunstone Corporation (which listed on NASDAQ), subsequently acquired by Sanofi in 2011, and later integrated into China Resources Sanjiu (CR Sanjiu) in 2017. Today, it operates as a key manufacturing and R&D hub for CR Sanjiu's pediatric and gynecological portfolio, utilizing advanced GMP-certified production lines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 太阳石.